Issue 12/2008
Content (15 Articles)
Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration
Gregory Driessens, Laurence Gordower, Lise Nuttin, Patrick Stordeur, Didier Blocklet, Dominique Egrise, Thierry Velu, Catherine Bruyns
Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors
Tania Benatar, Ming Y. Cao, Yoon Lee, Hui Li, Ningping Feng, Xiaoping Gu, Vivian Lee, Hongnan Jin, Ming Wang, Sandy Der, Jeff Lightfoot, Jim A. Wright, Aiping H. Young
Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8+ T cells-mediated protection against melanoma B16 challenge
Zaima Mazorra, Circe Mesa, Audry Fernández, Luis E. Fernández
Targeting activity of a TCR/IL-2 fusion protein against established tumors
Jinghai Wen, Xiaoyun Zhu, Bai Liu, Lijing You, Lin Kong, Hyung-il Lee, Kai-ping Han, Jeffrey L. Wong, Peter R. Rhode, Hing C. Wong
Selective accumulation of differentiated FOXP3+ CD4+ T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood
Camilla Jandus, Gilles Bioley, Daniel E. Speiser, Pedro Romero
Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo
Abdeljabar El Andaloussi, Yu Han, Maciej S. Lesniak
Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Asna Amin, Linda C. Benavides, Jarrod P. Holmes, Jeremy D. Gates, Mark G. Carmichael, Matthew T. Hueman, Elizabeth A. Mittendorf, Catherine E. Storrer, Yusuf H. Jama, Dianna Craig, Alex Stojadinovic, Sathibalan Ponniah, George E. Peoples
Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma
Michael J. Ciesielski, Danuta Kozbor, Carla A. Castanaro, Tara A. Barone, Robert A. Fenstermaker
Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus
Marinke Westerterp, Marja A. Boermeester, Jikke M. T. Omloo, Maarten C. C. M. Hulshof, Walter L. Vervenne, Rene Lutter, Theo A. Out, J. Jan B. van Lanschot
Immunomodulatory drugs Revlimid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
Dan Zhu, Laura G. Corral, Yuedi W. Fleming, Bernd Stein
Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity
Shinjiro Yamaguchi, Tomohide Tatsumi, Tetsuo Takehara, Akira Sasakawa, Hayato Hikita, Keisuke Kohga, Akio Uemura, Ryotaro Sakamori, Kazuyoshi Ohkawa, Norio Hayashi
RhoC a new target for therapeutic vaccination against metastatic cancer
Lynn Wenandy, Rikke Bæk Sørensen, Inge Marie Svane, Per thor Straten, Mads Hald Andersen
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
Michael M. Schmidt, Greg M. Thurber, K. Dane Wittrup
Intratumoral immunocytokine treatment results in enhanced antitumor effects
Erik E. Johnson, Hillary D. Lum, Alexander L. Rakhmilevich, Brian E. Schmidt, Meghan Furlong, Ilia N. Buhtoiarov, Jacquelyn A. Hank, Andrew Raubitschek, David Colcher, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
HLA typing demands for peptide-based anti-cancer vaccine
Dirk Nagorsen, Eckhard Thiel